Refractory Gastroesophageal Reflux Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Gastroesophageal Reflux Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Refractory Gastroesophageal Reflux Disease trials you may qualify forThe purpose of this program is to allow the use of domperidone in children from 12 to 21 years of age with symptoms related to motility disorders and Gastroesop…
This research study is evaluating the effectiveness of escalating doses of Amitriptyline and Duloxetine in reducing cough frequency in patients with refractory…
Among patients suffering from gastroesophageal reflux disease (GERD) symptoms, esophageal pH monitoring and the assessment of symptom-reflux correlation can ide…
The goal of this clinical trial is to learn if study drug Fosamprenavir-Sodium Alginate (FOS-SA) administered orally improves symptoms for Proton Pump Inhibitor…
This study will recruit patients aged 18-80 with refractory gastroesophageal reflux disease (GERD). These patients had a disease course of more than six months,…